ReceptoPharm
ReceptoPharm Homepage Contact Us Site Map
 
ReceptoPharm Homepage Products & Pipeline About ReceptoPharm
Developing Drugs to Save Lives

Investor Relations

You may contact ReceptoPharm for investor relations inquiries.

Corporate Headquarters:
ReceptoPharm, Inc.
1537 NW 65th Avenue
Plantation, FL 33313 USA

Phone: (954) 321-8988
Fax: (954) 321-9778

Business Development:
For licensing inquiries, please call us at (954) 321-8988.

Investor Relations:
For investor relations, please contact Nutra Pharma at (877) 895-5647.

 

Recent News
August 14, 2008
Nutra Pharma Announces Initial Positive Safety Data from Clinical Study in Adrenomyeloneuropathy (AMN)


August 6, 2008
Nutra Pharma Announces Collaborative Agreement with Centers for Disease Control and Prevention (CDC)


August 1, 2008
August 2008 Shareholder Letter from Chairman and CEO Rik J. Deitsch


 
 
Pipeline
 
E-Mail Updates
Automatically receive ReceptoPharm and Nutra Pharma news and other updates by e-mail as soon as it is released.